2023 annual financial data
Processa Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -11,457,061 USD and net income was -11,121,520 USD.
Operating cash flow was -8,063,346 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,457,061 USD
- Net income
- -11,121,520 USD
- Operating cash flow
- -8,063,346 USD